$350–$500+/mo
Typical direct-to-consumer prices through programs like LillyDirect and NovoCare — every month, indefinitely.
New Medicare program · Starts July 1, 2026
Medicare may finally cover your weight-loss medication — for about $50 a month.
The new Medicare GLP-1 Bridge covers brand-name Wegovy, Zepbound, and Foundayo for weight management — something Medicare has never done before. Answer a few questions, see how you line up with the published criteria, and walk into your doctor's office with everything they need to act.
Takes about 3 minutes · No Medicare ID or account needed · Independent educational tool — not affiliated with Medicare
If you've been paying out of pocket, this changes the math.
Until now, Medicare didn't cover GLP-1 medications for weight loss. People made do with expensive self-pay programs or took chances on compounded versions.
Uncertain
Advertised prices often exclude fees and consults — and quality and dosing consistency aren't FDA-approved.
~$50/mo copay
Brand-name Wegovy, Zepbound (KwikPen), or Foundayo for eligible Medicare beneficiaries who meet the published criteria.
Self-pay figures reflect typical published direct-to-consumer pricing and vary by drug and dose. The Bridge copay applies only if you're confirmed eligible and your clinician prescribes — this site can't promise either.
The catch: it's new, and the details matter.
The Bridge has specific criteria — BMI thresholds, qualifying conditions, exclusions, and an unusual pharmacy routing step. Many doctors haven't seen the program yet, because it doesn't exist until July 1. That's the friction this site removes.
Answer a few questions
Plan type, height and weight, health conditions — in plain English, free, right in your browser. Nothing is sent to a server.
See where you stand
We compare your answers to the published CMS criteria and flag anything that may route you to regular Part D instead.
Hand your doctor a ready-to-act packet
A portal message in your own voice, a one-page summary, and a prescriber reference sheet built from CMS's own instructions — diagnosis code, pharmacy note, and prior-authorization steps included.
The Bridge may be worth discussing if you…
- Have a Medicare drug plan (Part D or Medicare Advantage with drug coverage)
- Want a GLP-1 for weight reduction or maintenance — not another condition
- Had a BMI of 35+, or 30+ / 27+ with certain conditions, when starting therapy
- Pay cash today through LillyDirect, NovoCare, or a compounding pharmacy — that does not count against you
It likely routes elsewhere if you…
- Have type 2 diabetes, moderate-to-severe sleep apnea, or MASH (fatty liver disease) — those requests go through your regular Part D plan
- Already received a GLP-1 through your Part D plan
- Don't have Medicare drug coverage
The free screener sorts this out for you and explains what to ask your doctor either way.
Your doctor may not know this program yet. That's okay.
The Bridge launches July 1, 2026 and works differently from normal Part D coverage: the prescription needs an obesity diagnosis code (E66) and a special note — "SEND TO BRIDGE FOR WEIGHT MANAGEMENT" — so the pharmacy routes the claim correctly. Then the pharmacy sends your doctor a prior-authorization request, usually within 24–72 hours.
Our packet includes a clinician reference sheet summarizing those exact steps from CMS's prescriber fact sheet, so your doctor doesn't have to research a brand-new program to help you — and your request doesn't stall on a technicality.
Don't wait for July 1. Walk in ready.
The program opens July 1 — but Medicare appointments often book two to six weeks out, finding your starting weight can take some digging, and your doctor needs a moment to learn a brand-new program. Everything except the pharmacy claim can happen before launch day:
- Book the appointment now — by the time you're seen, the Bridge will be open
- Send your doctor the message and clinician sheet early, so the program homework is done before your visit, not during it
- Gather your documentation — drug plan card, starting weight, diagnosis records
- Be first in line — if your doctor agrees treatment is appropriate, your prescription can go out the day the program opens, while others are still asking their first question
Want a reminder before July 1?
Join the launch list and we'll let you know when the Bridge opens and if the published criteria change.
We'll email you when the Bridge launches and if the criteria change — nothing else. Unsubscribe anytime.
Learn more about the Medicare GLP-1 Bridge
Plain-English guides to how the program works, who it's for, and how to talk to your doctor about it.
What is the Medicare GLP-1 Bridge?
The short-term CMS program, what it covers, and why it exists.
Eligibility checklist
Gather your plan, BMI, diagnosis, and medication details before talking to your doctor.
Doctor letter guide
How to ask your doctor about the Bridge without overclaiming anything.
Common questions
Is it really about $50 a month?
The Bridge is designed around a low fixed copay for covered brand-name GLP-1 medications — a fraction of typical self-pay prices. The exact amount you pay depends on the program's terms at launch and your fill. We track the published CMS materials and update this site as details are finalized.
I pay cash for Wegovy/Zepbound now. Am I disqualified?
No — paying out of pocket (LillyDirect, NovoCare, or a compounding pharmacy) is not the same as receiving a GLP-1 through your Part D plan. The exclusion only applies to people who already got a GLP-1 through their Part D plan. The screener walks you through this distinction.
What if my doctor hasn't heard of the Bridge?
That's expected — it's brand new. Our packet includes a one-page clinician reference built from CMS's official prescriber fact sheet (CMS Product No. 12235): which drugs are covered, the diagnosis code and pharmacy note to use, and how the prior authorization arrives. Your doctor gets the "how," not just the request.
Is this an official Medicare site?
No. GLP1BridgeHelp.com is an independent educational tool, not affiliated with CMS, Medicare, HHS, drug manufacturers, or any Part D plan. We summarize published CMS materials and help you prepare for a conversation with your clinician.
Can this site tell me I qualify, or prescribe medication?
No. We show how your answers line up with the published criteria — "appears to match," "may not match," or "unclear." Only your clinician can decide whether a GLP-1 is medically appropriate, and only the Bridge program confirms eligibility.